MNK1 Kinase Assay Kit

Catalog #
78032
$1,750 *
Size: 96 reactions
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

The MNK1 Kinase Assay Kit is designed to measure MNK1 kinase activity for screening and profiling applications using ADP-Glo® Kinase Assay as a detection reagent. 
MBP (Myelin Basic Protein) is a non-specific protein substrate that is used as a "universal substrate" for many in-vitro kinase activity assays.  This protein is targeted by many serine/threonine kinases at conserved amino acids. We use the dephosphorylated version of the MBP substrate in our assays to determine the kinase-mediated phosphorylation of MBP.  Our assays are not suitable for studying autophosphorylation of the kinase due to the presence of the MBP substrate.

Synonyms
MAPK-interacting serine/threonine-protein kinase 1 kit
Product Info
Storage and Usage
Citations
Assay Kit Format
Luminescent
Supplied As
The MNK1 Kinase Assay Kit comes in a convenient 96-well format, with enough purified recombinant MNK1 enzyme, MBP, ATP, and kinase assay buffer for 100 enzyme reactions.
Materials Required But Not Supplied

ADP-Glo® Kinase Assay (Promega #V6930)
Dithiothreitol (DTT 0.5 M)
Microplate reader capable of reading luminescence
Adjustable micropipettor and sterile tips
30°C incubator

Format
Catalog
Number

Reagent

Amount

Storage
40078 MNK1 40 µg -80°C
Avoid
multiple
freeze/
thaw
cycles!
79334 5x Kinase assay buffer 1.5 ml -20°C
79686 ATP (500 μM) 50 µl -20°C
40535 MBP (5 mg/ml) 100 µl -20°C
79696 96-well plate, white 1 Room
Temp
 
UniProt #
Q9BUB5
Background

MAPK-interacting serine/threonine-protein kinase 1 (MNK1) is a member of the serine/threonine family that plays a role in mitotic cell cycle progression. Alteration of MNK1 has been shown in various cancers such as breast carcinoma and melanoma. MNK1 phosphorylates eukaryotic translation initiation factor 4E (eIF4E), enhancing phosphorylation of quiescent cells and rendering eIF4E oncogenic.

References

1. Chrestensen, C.A., et al. 2007. "MNK1 and MNK2 regulation in HER2-overexpressing breast cancer lines." Journal of Biological Chemistry 282(7): 4243-4252.
2. Dreas, A., et al. 2017. "Mitogen-activated protein kinase (MAPK) interacting kinases 1 and 2 (MNK1 and MNK2) as targets for cancer therapy: recent progress in the development of MNK inhibitors." Current Medicinal Chemistry 24(28): 3025-3053.